Yayınlar & Eserler

Yayın Ağı
Makaleler 8
Tümü (8)
SCI-E, SSCI, AHCI (6)
SCI-E, SSCI, AHCI, ESCI (7)
ESCI (1)
Scopus (5)
TRDizin (2)

1. Comparison of in vitro lipolysis, sequential lipolysis – ex vivo permeability, and simultaneous lipolysis - in situ perfusion for exemestane-loaded lipid-based formulations

Timur B., Olğaç S., Yılmaz Usta D., Demirel M. A., Teksin Z. Ş.
European Journal of Pharmaceutical Sciences , cilt.216, ss.1-19, 2026 (SCI-Expanded) Sürdürülebilir Kalkınma

2. Performance of oral Bosentan-loaded SNEDDS and S-SNEDDS tablets: Biodistribution in mice, echocardiography and histology studies in pulmonary arterial hypertension rat model

Yılmaz Usta D., Olğaç S., Demirel M. A., Kula S., Elmas Ç., Sezginer P., et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , cilt.212, sa.7, ss.1-18, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

3. Optimization and validation of HPLC methods for in vitro and ex vivo analyses of bosentan monohydrate in FDA-recommended and biorelevant media

Yılmaz Usta D., Olğaç S., Teksin Z. Ş.
Istanbul Journal of Pharmacy , cilt.54, sa.3, ss.466-475, 2024 (ESCI, TRDizin) Sürdürülebilir Kalkınma

4. Development and pharmacokinetic evaluation of Neusilin® US2-based S-SNEDDS tablets for bosentan: Fasted and fed states bioavailability, IVIS® real-time biodistribution, and ex-vivo imaging

Yılmaz Usta D., Olgac S., Tımur B., Teksin Z. Ş.
International Journal of Pharmaceutics , cilt.643, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

5. Development and Evaluation of Sustained Release Tablet Formulations of Venlafaxine Hydrochloride

Tort S., Kodan Akça E., Olğaç S., Saar S., Yıldız A., Ünal İ. S., et al.
Sağlık bilimlerinde değer (Online) , cilt.12, sa.1, ss.28-35, 2022 (TRDizin) identifier

6. Comparison of tablet splitting techniques for dosing accuracy of nebivolol tablets: Hand splitting versus tablet cutter and knife

Olgac S., Usta D. Y., İNCEÇAYIR T.
SAUDI PHARMACEUTICAL JOURNAL , cilt.29, sa.12, ss.1486-1491, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

7. Role of Surfactants on Dissolution Behavior of Tamoxifen

İNCEÇAYIR T., Olgac S., Usta D. Y., TEKSİN Z. Ş.
DISSOLUTION TECHNOLOGIES , cilt.28, sa.2, 2021 (SCI-Expanded, Scopus) identifier identifier

8. pH-dependent dissolution behavior of a weakly basic BCS class II drug, clopidogrel

İnceçayır T., Olğaç S., Yıldız A., Saar S., Kodan E.
Latin American Journal of Pharmacy , cilt.38, sa.10, ss.1921-1928, 2019 (SCI-Expanded, Scopus) identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 25

1. Formulation and Physicochemical Characterization of Interleukin-2 from Various Production Sources

OLĞAÇ S., DEMİRCİ H., DİNLER DOĞANAY G., KULAKMAN C., AKBAŞ Y., OLĞAÇ A., et al.
5th Conference on Innovation in Drug Delivery, Torino, İtalya, 1 - 03 Ekim 2025, (Özet Bildiri)

2. From In Silico to Cell Culture: Formulation Assessment of Human Interleukin-2

OLĞAÇ S., VARAN G., OLĞAÇ A., TEKSİN Z. Ş.
5th Conference on Innovation in Drug Delivery, Torino, İtalya, 1 - 03 Ekim 2025, (Özet Bildiri)

3. Formulation and Physicochemical Characterization of Interleukin-2 from Various Production Sources

OLĞAÇ S., DEMİRCİ H., DİNLER DOĞANAY G., KULAKMAN C., AKBAŞ Y., TEKSİN Z. Ş.
5th Conference on Innovation in Drug Delivery, Torino, İtalya, 1 - 03 Ekim 2025, (Özet Bildiri)

4. From In Silico to Cell Culture: Formulation Assessment of Human Interleukin-2

OLĞAÇ S., VARAN G., TEKSİN Z. Ş.
5th Conference on Innovation in Drug Delivery, Torino, İtalya, 1 - 03 Ekim 2025, (Özet Bildiri)

5. Assessment of in vitro release and in vitro lipolysis for interleukin-2-loaded double self-nanoemulsifying drug delivery system

OLĞAÇ S., TİMUR B., TEKSİN Z. Ş.
JOINT EUFEPS - ÖPhG Meeting 2025, Viyana, Avusturya, 19 - 21 Şubat 2025, (Özet Bildiri)

6. In vitro performance of Exemestan-loaded SNEDDS formulations: Dissolution in biorelevant media and antiproliferative activity on MCF-7 cell line

TİMUR B., VARAN G., OLĞAÇ S., YILMAZ USTA D., TEKSİN Z. Ş.
JOINT EUFEPS - ÖPhG Meeting 2025, Viyana, Avusturya, 19 - 21 Şubat 2025, (Özet Bildiri)

7. Exploring Protease Enzyme Selection for Protein-Structured Active Ingredient Loaded Drug Formulation with Molecular Dynamics Simulations

OLĞAÇ S., OLĞAÇ A., TEKSİN Z. Ş.
21st International Pharmaceutical Technology Symposium, Ankara, Türkiye, 9 - 11 Eylül 2024, (Özet Bildiri)

8. Evaluation of EXE-loaded SNEDDS using simultaneous lipolysis/ex-vivo permeability and lipolysis/in situ single-pass intestinal perfusion method

Timur B., Olğaç S., Yılmaz Usta D., Demirel M. A., Teksin Z. Ş.
21st International Pharmaceutical Technology Symposium, Ankara, Türkiye, 9 - 11 Eylül 2024, (Özet Bildiri) Sürdürülebilir Kalkınma

9. Development of Recombinant Human Interleukin-2 Loaded Double Nanoemulsions Using Microfluidizer® for Oral Drug Delivery

OLĞAÇ S., TEKSİN Z. Ş.
21st International Pharmaceutical Technology Symposium, Ankara, Türkiye, 9 - 11 Eylül 2024, (Özet Bildiri)

10. Screening and Assessment of Excipients for Nanoemulsion Formulations of İnterleukin-2 with Computational Studies

Olğaç S., Olğaç A., Teksin Z. Ş.
EUFEPS Annual Meeting 2023, Lisbon, Portekiz, 31 Mayıs - 02 Haziran 2023, (Özet Bildiri)

11. Histology and Pharmacodynamic Echocardiography Studies of Bosentan-Loaded SNEDDS and S-SNEDDS: New Oral Drug Delivery Systems for Pulmonary Arterial Hypertension

YILMAZ USTA D., OLĞAÇ S., DEMİREL M. A., KULA S., KAVGACI A., SEZGİNER P., et al.
EUFEPS Annual Meeting 2023, Lisbon, Portekiz, 31 Mayıs - 02 Haziran 2023, (Özet Bildiri)

12. Comparison of Tablet Splitting Techniques for Dosing Accuracy of Nebivolol Tablets: Hand Splitting Versus Tablet Cutter and Knife

OLĞAÇ S., YILMAZ USTA D., İNCEÇAYIR T.
3rd International Gazi Pharma Symposium Series (GPSS-2021), Türkiye, 8 - 10 Eylül 2021, (Özet Bildiri)

13. Development and Validated of UV Spectrophotometric and HPLC Method of Bosentan Monohydrate for In Vitro and Ex-Vivo Samples

YILMAZ USTA D., OLĞAÇ S., TEKSİN Z. Ş.
3rd International Gazi Pharma Symposium Series (GPSS-2021), Türkiye, 8 - 10 Eylül 2021, (Özet Bildiri)

14. Solid-State Characterization Studies of Bosentan-Loaded Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) Comprising of Neusilin® US2

YILMAZ USTA D., OLĞAÇ S., TEKSİN Z. Ş.
3rd International Gazi Pharma Symposium Series (GPSS-2021), Türkiye, 8 - 10 Eylül 2021, (Özet Bildiri)

15. Structure-Guided Selection of Suitable Nanoemulsion Formulation Components for a Recombinant Form of Human Interleukin-2 (Aldesleukin)

OLĞAÇ S., OLĞAÇ A., İNCEÇAYIR T., TEKSİN Z. Ş.
3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Türkiye, 8 - 10 Eylül 2021, (Özet Bildiri)

16. Validated HPLC Method for the Determination of Tenofovir and its Application for In-Vitro and Ex-Vivo Investigations of Tenofovir Loaded Double Nanoemulsion

Olğaç S., Yılmaz Usta D., Erman N. A., İnceçayır T., Teksin Z. Ş.
13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Türkiye, 22 - 25 Haziran 2021, (Özet Bildiri)

17. Modeling and comparison of in vitro dissolution profiles of naproxen sodium tablets in biorelevant media

OLĞAÇ S., YILMAZ USTA D., DEMİRDAŞ B., ERMAN N. A., TEKSİN Z. Ş.
13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Türkiye, 22 - 25 Haziran 2021, (Özet Bildiri)

18. Evaluation of In-vitro Dissolution Ex-vivo Permeability of Tenofovir Double Nanoemulsion Produced with the High Energy Method for Oral Drug Administration

Olğaç S., Yılmaz Usta D., İnceçayır T., Teksin Z. Ş.
EUFEPS Annual Meeting 2021, Stockholm, İsveç, 7 - 09 Haziran 2021, ss.65-66, (Özet Bildiri)

19. Production of Different Nanoemulsions with High Energy Method for Oral Drug Delivery

Olğaç S., İnceçayır T., Teksin Z. Ş.
12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Vienna, Avusturya, 11 - 14 Mayıs 2021, (Tam Metin Bildiri)

20. Evaluation of Fasted and Fed State Intestinal In Vitro Lipolysis Test for Bosentan Loaded Lipid-Based Drug Delivery Systems

TİMUR B., OLĞAÇ S., YILMAZ USTA D., TEKSİN Z. Ş.
8th BBBB International Conference on Pharmaceutical Science, İzmir, Türkiye, 14 - 16 Ekim 2019, (Tam Metin Bildiri)

21. Development and Characterization of Bosentan Loaded Solid Self Nanoemulsifying Drug Delivery System (S-SNEDDS)., Çeşme-İzmir, Türkiye

YILMAZ USTA D., OLĞAÇ S., TEKSİN Z. Ş.
8th BBBB International Conference on Pharmaceutical Science, İzmir, Türkiye, 14 - 16 Ekim 2019, (Tam Metin Bildiri)

22. Role of Surfactants and pH on Dissolution Behavior of Tamoxifen, a Weakly Basic BCS Class II Drug

OLGAÇ S., YILMAZ USTA D., İNCEÇAYIR T., TEKSİN Z. Ş.
AAPS PharmSci 360 Annual Meeting, Walter E. Washington Convention Center, Washington DC, USA, November 4-7, 2018, Washington, Kiribati, 4 - 08 Kasım 2018, (Özet Bildiri)

23. Modeling and Comparison of In-Vitro Dissolution Profiles of Tamoxifen Citrate Immediate Release Tablets

YILMAZ USTA D., OLGAÇ S., İNCEÇAYIR T., TEKSİN Z. Ş.
19th International Pharmaceutical Technology Symposium (IPTS 2018), Antalya, Turkey, p: 168-169, September 17-19, 2018, Antalya, Türkiye, 17 - 19 Eylül 2018, ss.168-169, (Tam Metin Bildiri)

24. pH-Dependent Dissolution Behavior Of a Weakly Basic BCS Class II Drug, Clopidogrel

OLĞAÇ S., YILDIZ A., SAAR S., KODAN E., İNCEÇAYIR T.
12th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

25. Development and Evaluation of Extended Release Tablet Formulations of Venlafaxine Hydrochloride

SAAR S., YILDIZ A., ÜNAL İ. S., ÖZDAL Z. D., OLĞAÇ S., KODAN E., et al.
12th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)
Metrikler

Yayın

33

Yayın (WoS)

7

Yayın (Scopus)

5

Atıf (WoS)

29

H-İndeks (WoS)

3

Atıf (Scopus)

29

H-İndeks (Scopus)

3

Atıf (Scholar)

20

H-İndeks (Scholar)

2

Atıf (Sobiad)

1

H-İndeks (Sobiad)

1

Proje

3
BM Sürdürülebilir Kalkınma Amaçları